Medical Properties (DE:M3P)
FRANKFURT:M3P
Holding DE:M3P?
Track your performance easily

Medical Properties (M3P) Income Statement

13 Followers

Medical Properties Income Statement

Last quarter (Q2 2024), Medical Properties's total revenue was $266.56M, a decrease of -20.99% from the same quarter last year. In Q2, Medical Properties's net income was $-320.63M. See Medical Properties’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 722.07M$ 871.80M$ 1.54B$ 1.54B$ 1.25B$ 854.20M
Cost of Revenue
$ 50.67M$ 41.57M$ -45.70M$ -39.10M$ -24.89M$ -23.99M
Gross Profit
$ 457.37M$ 830.23M$ 1.50B$ 1.51B$ 1.22B$ 878.19M
Operating Expense
$ 469.86M$ 748.95M$ 493.47M$ 466.89M$ 395.91M$ 248.72M
Operating Income
$ 24.74M$ 95.24M$ 928.84M$ 948.18M$ 735.72M$ 479.49M
Net Non Operating Interest Income Expense
$ 722.45M$ 410.89M$ -192.80M$ -198.70M$ -186.23M$ -87.86M
Other Income Expense
$ 351.08M$ -357.17M$ 221.68M$ -59.60M$ 14.54M$ -51.16M
Pretax Income
$ -1.70B$ -686.77M$ 959.72M$ 730.89M$ 463.33M$ 373.78M
Tax Provision
$ 39.55M$ -130.68M$ 55.90M$ 73.95M$ 31.06M$ -2.62M
Earnings From Equity Interest Net Of Tax
$ -402.30M$ 13.97M$ 40.80M$ 28.49M$ 20.42M$ 16.05M
Net Income Common Stockholders
$ -1.74B$ -556.48M$ 901.00M$ 653.86M$ 431.45M$ 422.67M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 507.56M$ 790.51M$ 447.77M$ 427.79M$ 371.02M$ 224.73M
Net Income From Continuing And Discontinued Operation
$ -1.74B$ -556.48M$ 902.60M$ 656.02M$ 431.45M$ 374.68M
Normalized Income
$ 298.24M-----
Interest Expense
------
EBIT
$ -903.25M$ -275.60M$ 1.00B$ 1.04B$ 828.44M$ 611.61M
EBITDA
$ -550.32M$ 356.30M$ 1.35B$ 1.37B$ 1.10B$ 777.07M
Currency in USD

Medical Properties Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis